Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery.
暂无分享,去创建一个
S. Ellis | E. Blackstone | M. Militello | L. Cho | Zhiyuan Sun | M. Cavender | A. Rassi | Gus Theodos
[1] M. Price,et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. , 2012, JAMA.
[2] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.
[3] Sean M. O'Brien,et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. , 2010, JAMA.
[4] M. Pencina,et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. , 2010, JACC. Cardiovascular interventions.
[5] S. de Servi,et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. , 2010, British journal of anaesthesia.
[6] M. Eisenberg,et al. Perioperative management of patients with drug-eluting stents. , 2010, JACC. Cardiovascular interventions.
[7] L. Thuesen,et al. Late coronary stent thrombosis. , 2010, Minerva medica.
[8] S. Ellis,et al. Characterization of post-operative risk associated with prior drug-eluting stent use. , 2009, JACC. Cardiovascular interventions.
[9] T. Geisler,et al. Perioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgery , 2009, Clinical Research in Cardiology.
[10] Jeffrey L. Anderson,et al. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[11] S. Steinhubl,et al. Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs. , 2007, American heart journal.
[12] Subhash Banerjee,et al. Perioperative management of patients with coronary stents. , 2007, Journal of the American College of Cardiology.
[13] Neville Kukreja,et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.
[14] D. Moliterno,et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Circulation.
[15] Patrick Whitlow,et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Journal of the American College of Cardiology.
[16] Patrick Whitlow,et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[17] David B Matchar,et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. , 2007, JAMA.
[18] Jeroen J. Bax,et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. , 2007, Journal of the American College of Cardiology.
[19] Robert M Califf,et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. , 2006, Journal of the American College of Cardiology.
[20] I. Palacios,et al. Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. , 2006, Journal of the American College of Cardiology.
[21] J. Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Circulation.
[22] W. Markiewicz,et al. Late thrombosis of sirolimus‐eluting stents following noncardiac surgery , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[23] Patrick W Serruys,et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. , 2005, Journal of the American College of Cardiology.
[24] I. Iakovou,et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.
[25] P. Vaitkus,et al. Risks of noncardiac surgery after coronary stenting. , 2005, The American journal of cardiology.
[26] Patrick W Serruys,et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy , 2004, The Lancet.
[27] R. Waksman,et al. Major noncardiac surgery following coronary stenting: When is it safe to operate? , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[28] P. Berger,et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. , 2003, Journal of the American College of Cardiology.
[29] D. Baim,et al. Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials , 2001, Circulation.
[30] A. Raizner,et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. , 2000, Journal of the American College of Cardiology.
[31] N. Orford,et al. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. , 2007, British journal of anaesthesia.
[32] Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. , 1998, The New England journal of medicine.